A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Public ClinicalTrials.gov record NCT02601885. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Escalating Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple Sclerosis
Study identification
- NCT ID
- NCT02601885
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Interventions
- ABT-555 Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 17, 2016
- Primary completion
- Apr 19, 2018
- Completion
- Apr 19, 2018
- Last update posted
- May 16, 2018
2016 – 2018
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Compass Research LLC | Orlando | Florida | 32806 | — |
| Rowe Neurology Institute | Lenexa | Kansas | 66214 | — |
| Parexel International | Baltimore | Maryland | 21225 | — |
| MIND | Farmington Hills | Michigan | 48334 | — |
| Duke Univ Med Ctr | Durham | North Carolina | 27710 | — |
| Tri-State Mountain Neurology | Johnson City | Tennessee | 37604 | — |
| Clinical Trial Network | Houston | Texas | 77074 | — |
| Integrated Neurology Services | Alexandria | Virginia | 22310 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02601885, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 16, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02601885 live on ClinicalTrials.gov.